Developing a class solution for Prostate Stereotactic Ablative Body Radiotherapy (SABR) using Volumetric Modulated Arc Therapy (VMAT)

Radiotherapy and Oncology

Volumn 110, Issue 2, 2014, Pages 298-302

  Murray, Louise J ^a,b   Cosgrove, Vivian ^a   Lilley, John ^a   Sykes, Jonathan ^a   Thompson, Christopher M ^a   Franks, Kevin ^a   Sebag Montefiore, David ^a,b   Henry, Ann M ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Image Guided RadioTherapy (IGRT); Prostate cancer; Stereotactic Ablative Body Radiotherapy (SABR); Volumetric Modulated Arc Therapy (VMAT)

Indexed keywords

ARTICLE; BLADDER; CLINICAL ARTICLE; COMPARATIVE STUDY; CONE BEAM COMPUTED TOMOGRAPHY; EARLY CANCER; FEMUR HEAD; HUMAN; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; INTESTINE; MALE; ORGANS AT RISK; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION RESPONSE; RADIOTHERAPY PLANNING SYSTEM; RECTUM; SEMINAL VESICLE; STEREOTACTIC ABLATIVE BODY RADIOTHERAPY; STEREOTACTIC BODY RADIATION THERAPY; VOLUMETRIC MODULATED ARC THERAPY; COMPUTER ASSISTED RADIOTHERAPY; PROCEDURES; PROSTATIC NEOPLASMS; RADIOSURGERY;

HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, IMAGE-GUIDED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84896402227     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.10.036     Document Type: Article

References (28)

1. EUROCARE. Survival of cancer patients in Europe. The EUROCARE-4 study. Survival analysis 1995-1999. 2009 [cited 2012 15.03.2012]; Available from: http://www.eurocare.it/Portals/0/CDEU4/Index.htm.
2. D.J. D'Ambrosio, A. Pollack, and E.E. Harris et al. Assessment of external beam radiation technology for dose escalation and normal tissue protection in the treatment of prostate cancer Int J Radiat Oncol Biol Phys 70 2008 671 677 (Pubitemid 351199720)
3. R. Miralbell, S.A. Roberts, E. Zubizarreta, and J.H. Hendry Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: alpha/beta = 1.4 (0.9-2.2) Gy Int J Radiat Oncol Biol Phys 82 2012 e17 24
4. D.A. Palma, W.F. Verbakel, K. Otto, and S. Senan New developments in arc radiation therapy: a review Cancer Treat Rev 36 2010 393 399
5. D. Palma, E. Vollans, and K. James et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 72 2008 996 1001
6. D. Wolff, F. Stieler, and G. Welzel et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer Radiother Oncol 93 2009 226 233
7. H. Quon, D.A. Loblaw, and P.C. Cheung et al. Intra-fraction motion during extreme hypofractionated radiotherapy of the prostate using pre- and post-treatment imaging Clin Oncol (R Coll Radiol) 24 2012 640 645
8. J. Adamson, Q. Wu, and D. Yan Dosimetric effect of intrafraction motion and residual setup error for hypofractionated prostate intensity-modulated radiotherapy with online cone beam computed tomography image guidance Int J Radiat Oncol Biol Phys 80 2011 453 461
9. C. Beltran, M.G. Herman, and B.J. Davis Planning target margin calculations for prostate radiotherapy based on intrafraction and interfraction motion using four localization methods Int J Radiat Oncol Biol Phys 70 2008 289 295 (Pubitemid 350251049)
10. P.A. Kupelian, K.M. Langen, T.R. Willoughby, O.A. Zeidan, and S.L. Meeks Image-guided radiotherapy for localized prostate cancer: treating a moving target Semin Radiat Oncol 18 2008 58 66 (Pubitemid 350235957)
11. Franzen LWA. Trial protocol: Fase III studie om hypofraktioneret strileterapi til patienter med prostatacancer I intermediaer riskogruppe-Hypo-RT-PC. Version 4; 2009.
12. Dearnaley D. CHHIP trial physics plan assessment form. 2006; Available from: http://rttrialsqa.dnsalias.org/chhip/ CHHIP%20Physics%20Plan%20Assessment%20Form%20v4%5B1%5D.0.pdf.
13. D. Dearnaley, I. Syndikus, and G. Sumo et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial Lancet Oncol 13 2012 43 54
14. L. Feuvret, G. Noel, J.J. Mazeron, and P. Bey Conformity index: a review Int J Radiat Oncol Biol Phys 64 2006 333 342 (Pubitemid 43083417)
15. ICRU Report 83. 3. Special considerations regarding absorbed-dose and dose-volume prescribing and reporting in IMRT J ICRU 10 2010 14
16. C.R. King, J.D. Brooks, H. Gill, and J.C. Presti Jr. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer Int J Radiat Oncol Biol Phys 82 2012 877 882
17. D.E. Freeman, and C.R. King Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes Radiat Oncol 6 2011 3
18. E.K. Oermann, S. Suy, and H.N. Hanscom et al. Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer J Hematol Oncol 4 2011 12
19. C.I. Tang, D.A. Loblaw, and P. Cheung et al. Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3 Clin Oncol (R Coll Radiol) 20 2008 729 737
20. N.C. Townsend, B.J. Huth, and W. Ding et al. Acute toxicity after cyberknife-delivered hypofractionated radiotherapy for treatment of prostate cancer Am J Clin Oncol 34 2011 6 10
21. T.P. Boike, Y. Lotan, and L.C. Cho et al. Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer J Clin Oncol 29 2011 2020 2026
22. S. Jabbari, V.K. Weinberg, and T. Kaprealian et al. Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response Int J Radiat Oncol Biol Phys 82 2012 228 234
23. National Cancer Action Team. national radiotherapy implementation group report. Stereotactic body radiotherapy clinical review of the evidence for SBRT. 2011 [cited 2012 16.08.2012]; Available from: http://www.ncat.nhs.uk/sites/ default/files/clinical%20evidence%20review%20Dec%2010%20-%20Final%20J11.pdf.
24. T. Seisen, S.J. Drouin, and V. Phe et al. Current role of image-guided robotic radiosurgery (Cyberknife((R))) for prostate cancer treatment BJU Int 111 2013 761 766
25. Agazaryan NTS, Chow P, et al. Volumetric arc therapy treatment protocol for hypo-fractionated stereotactic body radiotherapy for localised prostate cancer. Poster 3431 presented ASTRO 2010. 2011; Available from: http://astro2010.abstractsnet.com/handouts/011553-Agazaryan-Poster-ASTRO-2010- Final.pdf.
26. Miften MKB, Timmerman R, Diot Q, Papiez L. Volumetric modulated arc therapy for the stereotactic body radiation therapy of the prostate. Poster 3453 presented ASTRO 2011. 2011; Available from: http://astro2011.abstractsnet.com/ handouts/011567-Prostate-SBRT-ASTRO-2011.pdf.
27. A.N. Viswanathan, E.D. Yorke, L.B. Marks, P.J. Eifel, and W.U. Shipley Radiation dose-volume effects of the urinary bladder Int J Radiat Oncol Biol Phys 76 2010 S116 122
28. G. Hatiboglu, M. Pinkawa, J.P. Vallee, B. Hadaschik, and M. Hohenfellner Application technique: placement of a prostate-rectum spacer in men undergoing prostate radiation therapy BJU Int 110 2012 e647 652